O

ORIC Pharmaceuticals

Clinical-stage oncology company targeting resistance

Senior Regulatory Affairs Manager

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USA$175k - $200kHybrid

About the Job

Requirements

  • A bachelor's degree in a scientific or related field is required; an advanced degree is preferred.
  • Twelve years of experience with a bachelor's degree, or eight years of experience with a master's degree, or five years of experience with a PhD or PharmD.
  • Hands-on experience with U.S. IND submissions, EU CTA submissions in CTIS, CTA preparation and coordination outside the U.S., and health authority interactions and response management.
  • Experience managing IND and CTA lifecycle activities, including amendments, updates, and maintenance.
  • Experience preparing regulatory submissions such as INDs, DSURs, CTAs, and FDA meeting requests.
  • Strong communication, interpersonal, and collaboration skills across internal and external stakeholders.
  • Strong project management and organizational skills, with the ability to work independently, manage multiple projects simultaneously, and meet deadlines in a lean, fast-paced environment.
  • High attention to detail, problem-solving, and analytical thinking abilities.
  • Excellent writing and editorial skills, including the ability to develop clinical-regulatory documents such as investigator brochures, briefing documents, IND amendments, and Fast Track or ODD designation requests.
  • A strong scientific background and the ability to quickly acquire knowledge in therapeutic areas and the evolving regulatory landscape.
  • Familiarity with global regulatory requirements and guidelines, including FDA and ICH, and the ability to gather and analyze regulatory intelligence.
  • Computer expertise, including proficiency with Microsoft Office applications such as Word, Excel, and PowerPoint.
  • A flexible, proactive, hands-on mindset.

Responsibilities

  • Manage preparation and coordination of submissions to INDs or CTAs, including EU CTIS submissions and country-specific applications in regions outside the U.S.
  • Prepare and deliver timely, high-quality regulatory submissions with required documents that comply with applicable regulatory requirements.
  • Contribute regulatory guidance to strategic planning for assigned programs, including U.S., EU CTIS, and country-specific CTA processes.
  • Create, assemble, review, and archive complex regulatory submissions, coordinating with internal and CRO teams for execution.
  • Develop, manage, and track regulatory submission timelines.
  • Collaborate with regulatory operations, quality, CMC, nonclinical, and clinical teams.
  • Ensure submissions meet standards for accuracy, completeness, and consistency, and maintain health authority correspondence archives.
  • Review investigator packages and support site start-up activities from a regulatory perspective.
  • Analyze current regulatory issues, guidance, and initiatives, and communicate regulatory intelligence internally.
  • Contribute to the development and review of standard operating procedures to ensure regulatory compliance.
  • Perform duties in accordance with the company's core values, policies, and applicable regulations.

Desired Qualifications

  • Experience with a regulatory information management system such as Veeva RIM.

About the Company

ORIC Pharmaceuticals

Clinical-stage oncology company targeting resistance

ORIC Pharmaceuticals is a clinical-stage cancer company focused on overcoming how cancers resist treatment. Its therapies aim to restore patients’ response to existing treatments by targeting resistance mechanisms. Lead programs include rinzimetostat (ORIC-944), an allosteric inhibitor of the PRC2 complex designed for prostate cancer, and enozertinib (ORIC-114), a brain-penetrant inhibitor that targets EGFR exon 20 and HER2 exon 20 mutations in non-small cell lung cancer. Early work continues on other resistance mechanisms across solid tumors. Unlike some competitors, ORIC concentrates specifically on breaking or bypassing resistance to current therapies, based on research from Memorial Sloan Kettering Cancer Center and brought to Nasdaq-listed status in 2020. Its goal is to improve how well existing cancer treatments work for patients by keeping cancer from outsmarting them.

Company size
51-200
Company stage
IPO
Headquarters
South San Francisco, CA
Founded
2014

Recently Posted Jobs

Explore more opportunities at ORIC Pharmaceuticals

See more jobs